KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Shares Outstanding (Weighted Average) (2016 - 2025)

Idexx Laboratories (IDXX) has 13 years of Shares Outstanding (Weighted Average) data on record, last reported at $80.4 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 2.47% year-over-year to $80.4 million; the TTM value through Dec 2025 reached $80.4 million, down 2.47%, while the annual FY2025 figure was $80.4 million, 2.47% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $80.4 million in Q4 2025 per IDXX's latest filing, roughly flat from $80.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $85.5 million in Q1 2021 and bottomed at $80.1 million in Q3 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $83.1 million, with a median of $83.1 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 0.17% in 2021, then dropped 3.12% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $85.2 million in 2021, then decreased by 1.85% to $83.6 million in 2022, then dropped by 0.67% to $83.1 million in 2023, then fell by 0.72% to $82.5 million in 2024, then decreased by 2.47% to $80.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $80.4 million in Q4 2025, $80.1 million in Q3 2025, and $80.4 million in Q2 2025.